Our Pricing

Wegovy UK Price 2026: Complete Dosing and Cost Guide

Published on: June 03, 2026

Understanding the wegovy uk price 2026 landscape helps you make informed decisions about your weight loss journey. At Cured Pharmacy, Wegovy (semaglutide) is available from £79.00 across all dose strengths, with transparent upfront pricing and a free clinical consultation completed in under three minutes by our UK-registered prescribers.

How Wegovy Pricing Works in the UK

Wegovy pricing in the UK reflects several factors: the specific dose strength prescribed, supply chain dynamics, and whether you're purchasing through an online pharmacy or high-street outlet. At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures we maintain competitive pricing at £79.00 whilst guaranteeing genuine UK-licensed medication from authorised wholesalers.

Unlike some pharmacies that advertise low entry prices but add hidden consultation fees or delivery charges, our pricing model is transparent from the start. You'll see the exact cost before completing your clinical assessment, and there are no surprise charges at checkout. All prescription medications require online clinical assessment by a UK prescriber, which we provide free of charge as part of our service.

Wegovy Dose Escalation and Cost Implications

Wegovy follows a structured dose escalation schedule designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes. The treatment begins at 0.25mg weekly for four weeks, then increases monthly through 0.5mg, 1mg, and 1.7mg, reaching the maintenance dose of 2.4mg by week 17 [1].

This gradual titration schedule is based on the STEP clinical trial programme, where the 2.4mg maintenance dose produced an average 14.9% body weight reduction over 68 weeks in adults with obesity [1]. Each dose strength is priced identically at Cured Pharmacy, ensuring cost predictability throughout your treatment journey. Your UK prescriber will determine the appropriate starting dose and escalation schedule based on your medical history, current medications, and tolerance to treatment.

Why Dose Escalation Matters

The dose escalation protocol isn't arbitrary — it allows your body to adapt to semaglutide's effects on gastric emptying and satiety signalling. Patients who skip doses or escalate too quickly experience significantly higher rates of nausea, vomiting, and treatment discontinuation [2]. Our clinical team monitors your progress and can adjust the escalation timeline if you experience persistent side effects, ensuring you reach the therapeutic 2.4mg dose safely.

Wegovy vs Alternative Semaglutide Options

Semaglutide is available in the UK under two brand names: Wegovy (licensed specifically for weight management) and Ozempic (licensed for type 2 diabetes). Whilst both contain the same active ingredient, Wegovy is formulated in higher doses appropriate for obesity treatment, with the 2.4mg maintenance dose significantly exceeding Ozempic's maximum 1mg dose [3].

Some patients enquire about using Ozempic off-label for weight loss due to historical pricing differences. However, this practice presents clinical and regulatory concerns. Wegovy's licensing for weight management means it has been evaluated specifically for this indication by the MHRA, with dosing protocols and safety data tailored to obesity treatment. Our prescribers assess each patient individually and prescribe the most appropriate licensed medication for their clinical needs.

Clinical Efficacy Comparison

In head-to-head comparisons, the higher 2.4mg semaglutide dose used in Wegovy produces superior weight loss outcomes compared to the 1mg dose. The STEP 1 trial demonstrated that 2.4mg semaglutide resulted in 14.9% average body weight reduction, whilst studies of 1mg dosing for weight management showed approximately 9-10% reduction [1][2]. This dose-dependent response underscores why Wegovy's specific formulation and dosing schedule matter for optimal outcomes.

Stock Availability Across All Wegovy Doses

The UK experienced significant Wegovy supply constraints throughout 2023 and early 2024, with many pharmacies unable to stock the full dose range. As of 2026, Cured Pharmacy maintains stock across all five dose strengths (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg), ensuring continuity of care throughout your dose escalation journey.

Supply chain reliability matters particularly for weight loss medications, where treatment interruptions can compromise outcomes. Missing doses or reverting to lower strengths disrupts the carefully calibrated escalation protocol and may increase side effects when restarting. Our pharmacy team monitors stock levels daily and maintains relationships with multiple UK-licensed wholesalers to prevent supply gaps that could affect your treatment continuity.

What's Included in Your Wegovy UK Price

The £79.00 price at Cured Pharmacy includes several components that other providers may charge separately. Your purchase includes the Wegovy pen injector pre-filled with semaglutide, a free clinical consultation with a UK-registered prescriber (typically completed in under three minutes), discreet packaging with no external branding, and tracked delivery to your specified address.

We also provide ongoing clinical support throughout your treatment. If you experience side effects, have questions about injection technique, or need guidance on dose escalation timing, our pharmacy team is available via phone ((+44) 116 4646009) during business hours. This comprehensive service model ensures you receive not just medication, but complete clinical oversight from GPhC-registered professionals.

Transparent Pricing Policy

At Cured Pharmacy, we display prices before you begin your consultation — not after. This transparency allows you to make informed financial decisions about your treatment. There are no hidden consultation fees, no mandatory subscription models, and no pressure to purchase multi-month supplies upfront. You control your treatment timeline and can order monthly supplies as needed, subject to prescriber approval and clinical appropriateness.

How to Start Wegovy Treatment at Cured Pharmacy

Beginning Wegovy treatment requires three steps: completing an online clinical assessment, receiving prescriber approval, and arranging delivery. Our medical questionnaire takes under three minutes and covers your weight history, current medications, relevant medical conditions (particularly thyroid disorders and pancreatitis history), and weight loss goals. A UK-registered prescriber reviews your assessment, typically within hours during business days.

If Wegovy is clinically appropriate for you, the prescriber will issue a prescription and your order proceeds to our dispensary. We use 100% discreet packaging with no external indication of contents, and provide tracked delivery so you can monitor your shipment. Your first prescription will typically be for the 0.25mg starter dose, with subsequent prescriptions issued as you progress through the escalation schedule. Our clinical team will contact you before each dose increase to assess tolerance and confirm readiness to escalate [4].

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 0.25 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. https://products.mhra.gov.uk/ [accessed 13 August 2026]
4. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, lifestyle modifications, and individual metabolic factors.